Skip to main
IMAX

IMAX (IMAX) Stock Forecast & Price Target

IMAX (IMAX) Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 33%
Buy 56%
Hold 11%
Sell 0%
Strong Sell 0%

Bulls say

Imax Corp demonstrated impressive growth, evidenced by a 16.5% year-over-year revenue increase and a record global box office of $1.28 billion in 2025, which rose approximately 40% year-over-year. The company's strong performance is further highlighted by significant margin expansion, with consolidated gross margins increasing to 57.6% from 52.2% year-over-year, driven by growth in both Content Solutions and Technology Products and Services segments. Furthermore, the substantial box office achievements in diverse markets, including an 138% increase in China and a 66% increase in the rest of the world, underscore the brand's strong market presence and operational resilience.

Bears say

Imax Corporation's backlog of 434 has decreased from 440 at the end of the previous year, indicating potential challenges in maintaining demand for its technology and content solutions. The revised revenue forecast for Q4, lowered from $122.3 million to $120.5 million due to slightly weaker box office performance, underscores a declining trend compared to previous periods, notably from last year’s strong performance with Ne Zha 2. Additionally, lingering issues within the exhibition industry, exacerbated by the COVID-19 pandemic, suggest that despite Imax's positioning in high-performing complexes, the overall health of the industry poses risks to future growth and profitability.

IMAX (IMAX) has been analyzed by 9 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 56% recommend Buy, 11% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IMAX and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IMAX (IMAX) Forecast

Analysts have given IMAX (IMAX) a Buy based on their latest research and market trends.

According to 9 analysts, IMAX (IMAX) has a Buy consensus rating as of Mar 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $44.44, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $44.44, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IMAX (IMAX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.